Meanley Steven P, Stall Ron D, Dakwar Omar, Egan James E, Friedman Mackey R, Haberlen Sabina A, Okafor Chukwuemeka, Teplin Linda A, Plankey Michael W
Department of Family and Community Health, University of Pennsylvania School of Nursing, Philadelphia, PA.
Department of Behavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA.
Sex Res Social Policy. 2020 Jun;17(2):334-342. doi: 10.1007/s13178-019-00396-y. Epub 2019 Jun 26.
Conversion therapies are practices that attempt to change an individuals' same-sex attractions through psychotherapeutic and aversive therapeutic techniques. Conversion therapies were developed based on homophobic beliefs that same-sex attractions are a mental illness. We sought to describe the prevalence and characteristics of conversion therapy experienced among middle-aged and older men who have sex with men in the United States. Given associations of homophobic stigma and HIV risk, we hypothesized that HIV-positive men would report higher odds of conversion therapy compared to HIV-negative men. We analyzed data from 1,237 middle-aged and older MSM enrolled in the Multicenter AIDS Cohort Study. Among participants, 17.7% reported lifetime conversion therapy, of which the average start of therapy age was 22.67 ( = 10.56) years, 25.8% reported therapy durations of 6+ months, 37.7% reported session frequencies 1+ session per week, and 35.9% indicated that undergoing therapy was either a little or not at all their decision. We observed no statistically significant association between reporting lifetime conversion therapy and HIV status. Future efforts should continue to assess the magnitude of harm conversion therapies impose on MSM's health across the life course as well as test potential, indirect associations that may link these practices to HIV.
转化疗法是试图通过心理治疗和厌恶疗法技术来改变个体同性吸引倾向的做法。转化疗法是基于恐同观念发展而来的,这种观念认为同性吸引是一种精神疾病。我们试图描述美国中年及老年男男性行为者中经历过转化疗法的比例及其特征。鉴于恐同污名与感染艾滋病毒风险之间的关联,我们假设与艾滋病毒阴性男性相比,艾滋病毒阳性男性报告接受转化疗法的几率更高。我们分析了参与多中心艾滋病队列研究的1237名中年及老年男男性行为者的数据。在参与者中,17.7%报告有过终身转化疗法经历,其中疗法开始的平均年龄为22.67(标准差 = 10.56)岁,25.8%报告疗法持续时间为6个月及以上,37.7%报告治疗频率为每周1次及以上,35.9%表示接受治疗在很大程度上或完全不是他们自己的决定。我们观察到报告有终身转化疗法经历与艾滋病毒感染状况之间无统计学显著关联。未来的工作应继续评估转化疗法在整个生命历程中对男男性行为者健康造成的危害程度,以及检验可能将这些做法与艾滋病毒联系起来的潜在间接关联。